Skip to main content
. 2009 Jul;146(2):164–170. doi: 10.1111/j.1365-2141.2009.07728.x

Table IV.

Most common serious adverse events (N=1438).

Patients
Serious adverse event n %
Pneumonia 117 8·1
Pyrexia 54 3·8
Deep-vein thrombosis 43 3·0
Thrombocytopenia 42 2·9
Dehydration 36 2·5
Febrile neutropenia 36 2·5
Anaemia 35 2·4
Dyspnoea 29 2·0